PMV Pharmaceuticals, Inc.

Nasdaq:PMVP

Pharmaceutical Preparations·PRINCETON, NJ

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/6/26	→
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/9/25	→
10-K	FY 2024	12/31/24	3/3/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

22 shown

Filed	Period
3/6/26	Q1 FY2026	→
11/12/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/9/25	Q2 FY2025	→
3/3/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

18 shown

Filed	Type	Description
9/10/25	Reg FD	Regulation FD Disclosure	→
6/9/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/7/24	Vote	Submission of Matters to a Vote of Security Holders	→
1/18/24	Reg FD	Costs Associated with Exit or Disposal Activities	→
1/5/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/12/23	Other	Other Events	→
↓

Prospectuses & Registrations

18 shown

Filed	Form	Description
3/6/26	S-8	S-8	→
4/25/25	ARS	ARS	→
1/28/25	S-8	S-8	→
11/27/24	424B3	424B3	→
11/20/24	S-3	S-3	→
4/24/24	ARS	ARS	→
↓

Filing History(360 filings)

TypeDateAccessionPeriodSize

S-8

Mar 6, 2026

0001193125-26-095224S-8

—

185.8 KB

8-K

Mar 6, 2026

0001193125-26-0950948-K

Mar 6, 2026

319.3 KB

10-K

Mar 6, 2026

0001193125-26-09501410-K

Dec 31, 2025

12.5 MB

SCHEDULE 13D/A

Mar 4, 2026

0000947871-26-000231

—

24.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001163

—

6.8 KB

SCHEDULE 13G/A

Feb 9, 2026

0001373604-26-000014

—

6.3 KB

10-Q

Nov 12, 2025

0001193125-25-27600310-Q

Sep 30, 2025

8.0 MB

8-K

Nov 12, 2025

0001193125-25-2760008-K

Nov 12, 2025

372.1 KB

SCHEDULE 13G/A

Nov 12, 2025

0001214659-25-016264

—

8.4 KB

Oct 29, 2025

0001341642-25-000004

Oct 27, 2025

10.0 KB

Oct 27, 2025

0000947871-25-000927

Oct 23, 2025

7.9 KB

SCHEDULE 13D/A

Oct 27, 2025

0000947871-25-000926

—

24.0 KB

144

Oct 23, 2025

0000947871-25-000922

—

5.4 KB

SCHEDULE 13G

Sep 23, 2025

0001214659-25-014073

—

25.6 KB

Sep 12, 2025

0000947871-25-000854

Sep 10, 2025

7.9 KB

144

Sep 10, 2025

0000947871-25-000847

—

4.7 KB

8-K

Sep 10, 2025

0001193125-25-1998578-K

Sep 10, 2025

5.3 MB

SCHEDULE 13G/A

Aug 14, 2025

0001104659-25-078560

—

12.6 KB

SCHEDULE 13G/A

Aug 13, 2025

0001214659-25-011954

—

8.4 KB

10-Q

Aug 7, 2025

0000950170-25-10458810-Q

Jun 30, 2025

7.8 MB

8-K

Aug 7, 2025

0000950170-25-1045878-K

Aug 7, 2025

319.1 KB

Jul 3, 2025

0001415889-25-019386

Jul 1, 2025

4.9 KB

Jul 3, 2025

0001415889-25-019384

Jul 1, 2025

4.7 KB

Jul 3, 2025

0001415889-25-019382

Jul 1, 2025

4.8 KB

Jul 3, 2025

0001415889-25-019380

Jul 1, 2025

7.8 KB

25 filings shown

PMV Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(360 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/25/25	DEFA14A	DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
4/24/24	DEFA14A	DEFA14A	→
4/24/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
10/29/25	4	4	→
10/27/25	4	4	→
9/12/25	4	4	→
7/3/25	4	4	→
7/3/25	4	4	→
7/3/25	4	4	→
↓

Filed	Form	Description
3/4/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/9/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/12/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/27/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
10/23/25	144	144	→
↓